Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Studies on DNA Replication, Repair, and Mutagenesis in Eukaryotic and Prokaryotic Cells

Roger Woodgate
  • Roger Woodgate, PhD, Head, Section on DNA Replication, Repair and Mutagenesis
  • John P. McDonald, PhD, Biologist
  • Mary McLenigan, BS, Chemist
  • Sohail Ahmad, PhD, Postdoctoral Visiting Fellow
  • Douglas Lyra de Holanda Fonseca, PhD, Postdoctoral Visiting Fellow
  • Marcella T. Latancia, PhD, Postdoctoral Visiting Fellow
  • Mosonngwa C. Pule, PhD, Postdoctoral Visiting Fellow
  • Hanna M. Chu, BS, Postbaccalaureate Intramural Research Training Award Fellow
  • Jaan C. Selod, BS, Postbaccalaureate Intramural Research Training Award Fellow

Under optimal conditions, the fidelity of DNA replication is extremely high. Indeed, it is estimated that, on average, only one error occurs for every 10 billion bases replicated. However, given that living organisms are continually subjected to a variety of endogenous and exogenous DNA–damaging agents, optimal conditions rarely prevail in vivo. While all organisms have evolved elaborate repair pathways to deal with such damage, the pathways rarely operate with 100% efficiency. Thus, persisting DNA lesions are replicated, but with much lower fidelity than in undamaged DNA. Our aim is to understand the molecular mechanisms by which mutations are introduced into damaged DNA. The process, commonly referred to as trans-lesion DNA synthesis (TLS), is facilitated by one or more members of the Y-family of DNA polymerases, which are conserved from bacteria to humans. Based on phylogenetic relationships, Y-family polymerases may be broadly classified into five subfamilies: DinB–like (pol IV/pol kappa–like) proteins are ubiquitous and found in all domains of life; in contrast, the Rev1–like, Rad30A (pol eta)–like, and Rad30B (pol iota)–like polymerases are found only in eukaryotes; and the UmuC (polV)–like polymerases only in prokaryotes. We continue to investigate TLS in all three domains of life: bacteria, archaea, and eukaryotes.

Prokaryotic studies

polVR391 (Rum pol) DNA polymerase drives rapid bacterial drug resistance.

In collaboration with Myron Goodman, we investigated the acquisition of multidrug resistance by pathogenic bacteria, which is a well documented existential threat for healthcare systems globally. Bacteria use two principal strategies to adapt to antibiotic stress. They can obtain antibiotic resistance genes through horizontal gene transfer of mobile genetic elements, and they can acquire mutations in genes involved in antibiotic uptake and metabolism. Mobile genetic elements, including SXT/R391 Integrative Conjugative Elements (ICEs), are widely spread among bacterial pathogens, including clinical isolates of Escherichia coli and numerous species of Vibrio, Shewanella, and Klebsiella. SXT/R391 ICEs can facilitate rapid adaptation of host bacteria to changing environmental niches by contributing to genome plasticity and an expanded capacity to acquire novel traits, such as resistance to antibiotics, metals, and phage. SXT/R391 ICEs have been identified as key factors of antibiotic resistance in the seventh-pandemic lineage of V. cholerae, which remains a major cause of morbidity and mortality worldwide. Many ICEs encode homologs of the highly error-prone E. coli pol V (chromosomally encoded umuDC). Pol V (UmuD′2 C) is induced in E. coli as part of the SOS regulon (a global regulatory transcriptional response to DNA damage), and its expression is required to observe mutations above spontaneous background levels for cells irradiated with UV and exposed to chemicals that damage DNA. In R391, highly mutagenic polVR391 (Rum pol) is encoded by rumAB. Our collaborative study revealed that, even under tight transcriptional and post-transcriptional regulation imposed by host bacteria and the R391 ICE itself, Rum pol rapidly accelerated development of Ciprofloxacin-, Rifampicin-, and Ampicillin-resistance in E. coli in response to the SOS–inducing antibiotic and non-antibiotic external stressors Bleomycin, Ciprofloxacin, and UV-radiation. The impact of Rum pol on the rate of acquisition of drug resistance appears to surpass potential contributions from other cellular processes. We also discovered that RecA protein (a 38 kDa protein essential for DNA repair and maintenance in bacteria) plays a central role in controlling the ability of Rum pol to accelerate antibiotic resistance. Indeed, a single amino acid substitution in RecA, M197D, acts as a ‘Master Regulator’ that effectively eliminates the Rum pol–induced antibiotic resistance. We hypothesized that Rum pol should therefore be considered as one of the major factors driving development of de novo antibiotic resistance in pathogens carrying SXT/R391 ICEs.

Publications

  1. Jaszczur MM, Pham P, Ojha D, Pham CQ, McDonald JP, Woodgate R, Goodman MF. Pathogen-encoded Rum DNA polymerase drives rapid bacterial drug resistance. Nucleic Acids Res 2024 52:12987-13002

Collaborators

  • Irina Bezsonova, PhD, University of Connecticut, Farmington, CT
  • Rodrigo Galhardo, PhD, University of São Paulo, São Paulo, Brazil
  • Martín Gonzalez, PhD, Southwestern University, Georgetown, TX
  • Myron F. Goodman, PhD, University of Southern California, Los Angeles, CA
  • Digby Warner, PhD, University of Cape Town, Cape Town, South Africa
  • Wei Yang, PhD, Laboratory of Molecular Biology, NIDDK, Bethesda, MD